MeSH term
Frequency | Condition_Probility | Base Sequence | 6 | 0.0 |
DNA Primers | 3 | 0.0 |
Hemolysins/*genetics | 5 | 62.0 |
Humans | 57 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 25 | 0.0 |
Vibrio parahaemolyticus/classification/*genetics/isolation & purification | 2 | 100.0 |
Caco-2 Cells | 3 | 0.0 |
Calcium/metabolism | 5 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Chloride Channels/antagonists & inhibitors | 2 | 40.0 |
Vibrio parahaemolyticus/*metabolism | 3 | 100.0 |
Adolescent | 5 | 0.0 |
Adult | 12 | 0.0 |
Female | 10 | 0.0 |
*Linguistics | 2 | 50.0 |
Male | 9 | 0.0 |
Middle Aged | 9 | 0.0 |
Neuropsychological Tests | 3 | 1.0 |
English Abstract | 10 | 0.0 |
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/pharmacology | 2 | 7.0 |
Cell Line | 3 | 0.0 |
Chlorides/*metabolism | 2 | 2.0 |
Vibrio parahaemolyticus/*pathogenicity | 8 | 88.0 |
Hemolysins/*toxicity | 4 | 80.0 |
Animals | 12 | 0.0 |
*Bacterial Proteins | 5 | 2.0 |
DNA, Bacterial/analysis | 2 | 3.0 |
Environmental Microbiology | 2 | 40.0 |
Food Microbiology | 2 | 6.0 |
Hemolysins/*biosynthesis/*genetics | 2 | 100.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Vibrio Infections/microbiology | 3 | 100.0 |
Aged | 5 | 0.0 |
Diaphragm/*injuries | 2 | 100.0 |
Rupture | 2 | 13.0 |
Hemolysis | 3 | 0.0 |
Texas/epidemiology | 3 | 10.0 |
Comparative Study | 7 | 0.0 |
Electrophoresis, Gel, Pulsed-Field | 2 | 0.0 |
Japan/epidemiology | 4 | 1.0 |
Serotyping | 7 | 3.0 |
Asia, Southeastern | 2 | 10.0 |
Diarrhea/*microbiology | 4 | 30.0 |
Enterobacteriaceae/*isolation & purification | 2 | 50.0 |
Japan | 3 | 0.0 |
Salmonella/isolation & purification | 3 | 100.0 |
*Travel | 3 | 11.0 |
Aphasia, Broca/*diagnosis | 2 | 100.0 |
Language Tests | 2 | 13.0 |
Rabbits | 5 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Food Poisoning/microbiology | 3 | 42.0 |
*Genes, Bacterial | 7 | 10.0 |
Genotype | 3 | 0.0 |
Phenotype | 3 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Potassium/metabolism | 2 | 1.0 |
Hemolysins/genetics/metabolism/*toxicity | 2 | 66.0 |
In Vitro | 3 | 0.0 |
Mutation | 3 | 0.0 |
Virulence | 4 | 1.0 |
Disease Models, Animal | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Child | 3 | 0.0 |
Diarrhea/microbiology | 3 | 21.0 |
DNA, Bacterial/genetics | 3 | 4.0 |
Vibrio Infections/*microbiology | 3 | 60.0 |
Vibrio parahaemolyticus/*genetics | 2 | 100.0 |
Gastroenteritis/microbiology | 2 | 28.0 |
Quarantine | 2 | 100.0 |
Shigella/isolation & purification | 2 | 100.0 |
Cell Membrane Permeability/drug effects | 3 | 5.0 |
Brain/physiopathology | 2 | 3.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Urease/*biosynthesis | 2 | 100.0 |
DNA Probes | 2 | 0.0 |
Feces/chemistry | 2 | 4.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Temperature | 2 | 0.0 |
Hemolysis/drug effects | 3 | 5.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Mice | 2 | 0.0 |
Prevalence | 2 | 0.0 |
Shellfish/microbiology | 2 | 100.0 |
